Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis

OBJECTIVE: The toxicity associated with the use of kanamycin includes irreversible hearing loss. There is limited data describing the relationship between hearing loss and kanamycin pharmacokinetics (PK). We explored the association of kanamycin PK with hearing loss in patients on MDR-TB treatment....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Audiol
Главные авторы: Ghafari, Nazanin, Court, Richard, Chirehwa, Maxwell Tawanda, Wiesner, Lubbe, Petersen, Lucretia, Maartens, Gary, Gumbo, Tawanda, McIlleron, Helen, Ramma, Lebogang
Формат: Artigo
Язык:Inglês
Опубликовано: 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7582222/
https://ncbi.nlm.nih.gov/pubmed/31739701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14992027.2019.1690170
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы